Transformation-associated Epstein-Barr virus antigens as targets for immune attack.
Masucci
M G
MG
Department of Tumor Biology, Karolinska Institute, Stockholm, Sweden.
Gavioli
R
R
de Campos-Lima
P O
PO
Zhang
Q J
QJ
Trivedi
P
P
Dolcetti
R
R
D000595:Amino Acid Sequence; D000956:Antigens, Viral / Q000276:immunology*; D002051:Burkitt Lymphoma / Q000276:immunology / Q000382:microbiology; D002472:Cell Transformation, Viral; D004268:DNA-Binding Proteins / Q000276:immunology; D000939:Epitopes; D019309:Epstein-Barr Virus Nuclear Antigens; D015967:Gene Expression Regulation, Viral; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000276:immunology; D006801:Humans; D008969:Molecular Sequence Data; D009303:Nasopharyngeal Neoplasms / Q000276:immunology / Q000382:microbiology; D010455:Peptides / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D000956:Antigens, Viral; D004268:DNA-Binding Proteins; D000939:Epitopes; D019309:Epstein-Barr Virus Nuclear Antigens; D015395:Histocompatibility Antigens Class I; D010455:Peptides